Michael Chansler

Michael Chansler

Company: Savid Therapeutics

Job title: Vice President, Business Development


AMDC – Antibody Mimetic Drug Conjugates: Precision Engineered Medicines 1:40 pm

Discussing Cupid-Pysche: A novel and proprietary platform delivering a variety of payloads to multiple tumor associated antigen targets Analyzing a system for the rapid in vivo validation of antibody mimetic targeting ligands and the evaluation of therapeutic payloads including chemotherapeutics, immunotherapies, alpha emitting radioisotopes, and a proprietary photoimmunotherapyRead more

day: Scientific Program Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.